My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Deus Medical Deus Medical
Tirzepatide
Tirzepatide - Deus Medical

Tirzepatide - Deus Medical

Brand:
Deus Medical
Category:
Peptides
Substance:
Tirzepatide
Package:
10 mg
Price:
0
See options
Product Overview
Tirzepatide, marketed as Mounjaro®, is the first dual GIP/GLP-1 receptor agonist, approved by the FDA in 2022 for type 2 diabetes. By targeting two incretin pathways, it delivers superior reductions in blood glucose and body weight compared to traditional GLP-1RAs. Clinical trials, including SURPASS-4, showed not only strong glycemic control but also lower mortality versus insulin glargine during the COVID-19 era. With a well-tolerated profile and potential applications beyond diabetes, tirzepatide marks a major innovation in managing complex metabolic diseases.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by Deus Medical, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
Does Tirzepatide have an impact on long-term diabetes outcomes?
Tirzepatide’s effects on weight and HbA1c suggest it may improve long-term outcomes, especially with regular use.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Why might doctors choose Tirzepatide over other drugs?
Because it treats both high blood sugar and excess weight in one weekly dose, improving convenience and results.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

What makes Tirzepatide important in modern diabetes care?
Its ability to act on two hormone systems at once sets a new standard for managing metabolic diseases.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.